Susquehanna International Group
CUE icon

Susquehanna International Group’s Cue Biopharma CUE Stock Holding History

Susquehanna International Group’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.66K Sell
820
-4,808
-85% -$44.9K ﹤0.01% 12979
2025
Q4 		$51.6K Buy
5,628
+79
+1% +$1.45K ﹤0.01% 11740
2025
Q3 		$120K Buy
5,549
+408
+8% +$9.57K ﹤0.01% 11456
2025
Q2 		$105K Buy
+5,141
New +$110K ﹤0.01% 11770
2025
Q1 		– Sell
-442
Closed -$14.5K – 12614
2024
Q4 		$14.5K Buy
+442
New +$16.6K ﹤0.01% 11952
2024
Q3 		– Sell
-3,991
Closed -$148K – 12137
2024
Q2 		$148K Buy
3,991
+2,869
+256% +$142K ﹤0.01% 10705
2024
Q1 		$63.6K Buy
1,122
+659
+142% +$46.5K ﹤0.01% 11458
2023
Q4 		$36.7K Sell
463
-1,962
-81% -$140K ﹤0.01% 11827
2023
Q3 		$167K Buy
2,425
+236
+11% +$23K ﹤0.01% 10436
2023
Q2 		$240K Sell
2,189
-2,229
-50% -$262K ﹤0.01% 9901
2023
Q1 		$473K Buy
+4,418
New +$421K ﹤0.01% 8700
2022
Q4 		– Sell
-952
Closed -$87.1K – 12602
2022
Q3 		$64K Sell
952
-4,548
-83% -$391K ﹤0.01% 12044
2022
Q2 		$411K Buy
5,500
+3,143
+133% +$368K ﹤0.01% 8753
2022
Q1 		$345K Buy
2,357
+774
+49% +$164K ﹤0.01% 9920
2021
Q4 		$537K Buy
1,583
+623
+65% +$241K ﹤0.01% 8992
2021
Q3 		$420K Sell
960
-544
-36% -$190K ﹤0.01% 9821
2021
Q2 		$526K Sell
1,504
-378
-20% -$147K ﹤0.01% 9457
2021
Q1 		$689K Buy
1,882
+1,107
+143% +$456K ﹤0.01% 8703
2020
Q4 		$291K Sell
775
-238
-23% -$95.1K ﹤0.01% 9317
2020
Q3 		$458K Buy
1,013
+261
+35% +$150K ﹤0.01% 7858
2020
Q2 		$553K Buy
+752
New +$545K ﹤0.01% 7158

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
GWMR
GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
AWM
Angeles Wealth Management Santa Monica, California $2.19B AUM 23.13% 1-Year Est. Return

Susquehanna International Group's CUE Position: Q1 2026 in Review

Susquehanna International Group reduced its Cue Biopharma (CUE) stake by 85% in Q1 2026, selling an estimated $44.9K and leaving 820 shares worth $5.66K. The position accounts for ﹤0.01% of the portfolio, ranked #12979.

Susquehanna International Group first reported a position in CUE in Q2 2020 and has held it in 21 quarters since. The position peaked at $689K in Q1 2021. 55 funds tracked by Wall St. Rank hold CUE as of Q1 2026.

  • Susquehanna International Group held 820 shares of Cue Biopharma worth $5.66K as of Q1 2026.
  • Susquehanna International Group sold 4,808 Cue Biopharma shares in Q1 2026, an estimated $44.9K.
  • Cue Biopharma made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12979 holding.
  • Susquehanna International Group first reported a position in Cue Biopharma in Q2 2020 and has held it in 21 quarters since.
  • Susquehanna International Group's Cue Biopharma position peaked at $689K in Q1 2021.
  • 55 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.